Roche Corporation

Yubo Biology

Advantage supply, genuine product guarantee*

whole country:

Roche SwitzerlandRoche www.roche.com.cn www.roche.com
Roche was founded in1896In, headquartered in Basel, Switzerland, it is one of the world's leading healthcare companies based on research and development and driven by innovation in the fields of pharmaceuticals and diagnostics. Roche is committed to two core businesses——Medicines and diagnostics provide innovative products and services from early detection, prevention, diagnosis to treatment, thereby improving human health and quality of life. Roche is a pioneer in the field of in vitro diagnostics, anti-tumor drugs, and transplant drugs; It is a market in the field of virology and other key disease areas such as autoimmune diseases, inflammation, metabolism, and central nervous system diseases. After more than a century of development, Roche Group's business has spread all over the world150Multiple countries, collectively possessing approximately75,000We have established research and development business alliances with multiple partners, including Roche Holdings' Genentech in the United States and Sino foreign Pharmaceuticals in Japan. Roche focuses on sustainable development and maintains good operational performance,2006Roche Group's pharmaceutical sales reached333Billion Swiss francs, sales revenue of the diagnostic department is87One billion Swiss francs.
Roche is one of the research-oriented health companies in the world, founded in1896Year, headquartered in Basel, Switzerland. After a century of history, Roche's business has now spread all over the world150Multiple countries, jointly owned65,000Multiple employees. Roche's two core businesses——Medicines and diagnostics provide innovative products and services for prevention, diagnosis, and treatment of human health, thereby improving human health standards and quality of life.2003In the year, the sales revenue of Roche Group's core business reached290One billion Swiss francs.
Roche has become a leader in many fields:
·Ranking in the field of diagnosis*
·Ranking in the field of oncology*
·Researchers in the fields of transplantation and virology
·Biotechnology field * 2
Roche traditionally calculates the annual sales revenue based on15%The proportion of investment in scientific research and development is the highest among peers. This tradition of emphasizing scientific research has not only enabled Roche to develop a variety of breakthrough new drugs and achieve considerable economic benefits, but also has outstanding social benefits in promoting human health. Roche scientists have won the Nobel Prize three times for this. Currently, Roche has10There are research and development centers located in Basel, Switzerland, Natley, and Palo Alto, USA. Among them, Roche Basel's Center for Central Nervous System and Cardiovascular Disease Research and the Gene Research Center in the United States enjoy a high reputation in the pharmaceutical industry.2004year1Roche announced the establishment of its fifth research and development center for pharmaceuticals in Shanghai, China. This will be Roche establishing research and development facilities in developing countries.
Roche's pharmaceutical production department has a long history, mainly producing drugs for the treatment of various diseases such as central nervous system diseases, infectious diseases, inflammation, cardiovascular diseases, tumors, viral infections, skin diseases, obesity, etc. In order to increase the variety of drugs and explore innovation, Roche has successfully acquired some large pharmaceutical companies in recent years to strengthen its own strength. This includes acquiring a majority stake in Gene Technologies, a biotechnology company based in the United States, to strengthen Roche's expertise in genetic engineering——The position in this field of the pharmaceutical industry; Acquired the over-the-counter drug division of Nicolas and Fresens, making Roche the largest company in the European over-the-counter drug market;1994In the year, Roche acquired Sinovac Pharmaceuticals, doubling its strength in anti infective and organ transplant drugs.2001In the year, Roche and Japanese domestic and foreign pharmaceutical companies announced the establishment of a research oriented Japanese pharmaceutical company, which is a fully functional multinational corporation based in Japan and ranks among the top*2Large drug sales market——The Japanese market5Position.
Roche Medical Diagnostics Department1968After its establishment, it developed at an astonishing speed. The reagents produced by this department are widely used in medical immunology experiments, such as pregnancy testing, hepatitis testing, HIV testing, etc.1994In, Roche's biomedical laboratory merged with the National Health Laboratory in the United States to form the world's largest clinical medical laboratory organization--The American laboratory organization, of which Roche owns49.9%The shares. In terms of medical diagnosis, Roche Molecular Laboratory is another top performing research institution of Roche. The laboratory is currently dedicated to polymerase chain reaction technologyPCRThe research shows that this technology can integrate the same gene orDNAFragment duplication can be widely used in basic research, AIDS, tuberculosis, leukemia diagnosis and environmental testing.1998At the beginning of the year, Roche completed the merger with Baolingman Company, absorbing the company's product advantages and becoming a leader in the field of pharmaceutical diagnostics.2003In, Roche successfully acquired the second largest insulin pump manufacturer in SwitzerlandDisetronicThe company has made Roche Diagnostics, which is in the field of diabetes monitoring, a major zui supplier of diabetes integrated control system equipment.
1896Haofumai·Roche Corporation was established
1919Roche transforms from a family company to a limited company
1933Industrial synthesis of vitaminsC
1938-1947vitaminAVitaminsBGroups, vitaminsEIndustrial synthesis
1963Acquisition of Qihuadun essence Flavor Company
1964Acquisition of Roa Company
1968Establish a Diagnostic Product Department
1968Establishing Roche Molecular Biology Institute in Natley, USA
1971Roche Immunology Institute completed in Basel
1974The anti Parkinson's disease drug Madopar（Madopar）Received the Galen Award
1975*Mass production of monoclonal antibodies
1980Started collaborating with Genentech Corporation in the United States
1984*The medication that can truly effectively treat severe psoriasis can be loosened（Tight）Received the Galen Award
1984Professor Nelskaya Jahn and Dr. Georg Skoler, who work at Roche Basel Institute for Immunology, have been awarded the Nobel Prize in Physiology or Medicine
1986A specialized research group on vision and life has been established to prevent and treat vitamins for infants and children in developing countriesALack of assistance provided
1987scientistSusumu TonegowaReceived the Nobel Prize in Medicine for his outstanding contributions at the Basel Institute of Immunology
1988Benzodiazepine antagonist Anyixing（Anexate）Won the Galen Award
1989Establishment of Roche Holdings Limited
1990Acquisition of non prescription drug manufacturer Nicolas Group
1991Qihuadun Royal was established to form Roche's essence and fragrance department
1991Neupogen（Neupogen）Received the European Galen Award
1994Acquisition of Sintek Corporation in the United States
1995Pulmozyme(Pulmozyme)Winning the Galen Award
1997Acquired Teshimei Company, an American spice manufacturer, and then merged into essence and Fragrance Department
1997Acquisition of Baolingman and Depp Company
1997Due to wearing thunder（Invirase）Winning the Galen Award
1998The biotechnology research and production center in Pentzberg, Germany has been completed
1999Starting with IcelanddeCodecompany cooperation
1999Fully acquire Genentech Corporation
2000Roche divests essence and spice business
2001Roche Japan and Sinopharm announced a merger to jointly establish a new pharmaceutical company in Japan
2002Roche announced the divestment of its Vitamin and Fine Chemicals division, allowing the group to focus more on its healthcare business
2003Roche acquires SwitzerlandDesignThe company further strengthens its advantages in the field of diabetes treatment